参考文献

[1] Ley R E,Peterson D A,Gordon J I.Ecological and evolutionary forces shaping microbial diversity in the human intestine[J].Cell,2006,124(4):837-848.

[2] Metchnikoff E.The prolongation of life:optimistic studies[M].New York:GP Putnam's Sons,1907.

[3] Backhed F,Ding H,Wang T,et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proceedings of the National Academy of Sciences of the United States of America,2004,101(44):15718-15723.

[4] Noah T K,Donahue B,Shroyer N F.Intestinal development and differentiation[J].Experimental Cell Research,2011,317(19):2702-2710.

[5] Ahlman H,Nilsson.The gut as the largest endocrine organ in the body[J].Annals of Oncology,2001,12 Suppl 2:S63.

[6] Martin A M,Sun E W,Keating D J.Mechanisms controlling hormone secretion in human gut and its relevance to metabolism[J].Journal of Endocrinology,2019,244(1):R1-R15.

[7] Jun L S,Millican R L,Hawkins E D,et al.Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production[J].Diabetes,2015,64(3):819-827.

[8] Zmora N,Suez J,Elinav E.You are what you eat:diet,health and the gut microbiota[J].Nature Reviews:Gastroenterology&Hepatology,2019,16(1):35-56.

[9] Beutler L R,Chen Y,Ahn J S,et al.Dynamics of gut-brain communication underlying hunger[J].Neuron,2017,96(2):461-475.

[10] Burmeister M A,Ayala J E,Smouse H,et al.The hypothalamic glucagon-like peptide 1 receptor is sufficient but not necessary for the regulation of energy balance and glucose homeostasis in mice[J].Diabetes,2017,66(2):372-384.

[11] Chen Y,Lin Y C,Kuo T W,et al.Sensory detection of food rapidly modulates arcuate feeding circuits[J].Cell,2015,160(5):829-841.

[12] Grasset E,Puel A,Charpentier J,et al.A specific gut microbiota dysbiosis of type 2 diabetic mice induces glp-1 resistance through an enteric no-dependent and gut-brain axis mechanism[J].Cell Metabolism,2017,25(5):1075-1090.

[13] Torres-Fuentes C,Schellekens H,Dinan T G,et al.The microbiota-gut-brain axis in obesity[J].Lancet Gastroenterol Hepatol,2017,2(10):747-756.

[14] Brown E M,Sadarangani M,Finlay B B.The role of the immune system in governing host-microbe interactions in the intestine[J].Nature Immunology,2013,14(7):660-667.

[15] Cani P D.Human gut microbiome:hopes,threats and promises[J].Gut,2018,67(9):1716-1725.

[16] Sekirov I,Russell S L,Antunes L C,et al.Gut microbiota in health and disease[J].Physiological Reviews,2010,90(3):859-904.

[17] Clarke G,Sandhu K V,Griffin B T,et al.Gut reactions:breaking down xenobiotic-microbiome interactions[J].Pharmacological Reviews,2019,71(2):198-224.

[18] Frank D N,Pace N R.Gastrointestinal microbiology enters the metagenomics era[J].Curr Opin Gastroenterol,2008,24(1):4-10.

[19] Andersson A F,Lindberg M,Jakobsson H,et al.Comparative analysis of human gut microbiota by barcoded pyrosequencing[J].PloS One,2008,3(7):e2836.

[20] Jandhyala S M,Talukdar R,Subramanyam C,et al.Role of the normal gut microbiota[J].World Journal of Gastroenterology,2015,21(29):8787-8803.

[21] Hollister E B,Gao C,Versalovic J.Compositional and functional features of the gastrointestinal microbiome and their effects on human health[J].Gastroenterology,2014,146(6):1449-1458.

[22] Turnbaugh P J,Ley R E,Hamady M,et al.The human microbiome project[J].Nature,2007,449(7164):804-810.

[23] Goodrich J K,Waters J L,Poole A C,et al.Human genetics shape the gut microbiome[J].Cell,2014,159(4):789-99.

[24] Blandino G,Inturri R,Lazzara F,et al.Impact of gut microbiota on diabetes mellitus[J].Diabetes and Metabolism,2016,42(5):303-315.

[25] Mclaughlin R W,Cochran P A,Dowd S E.Metagenomic analysis of the gut microbiota of the Timber Rattlesnake,Crotalus horridus[J].Molecular Biology Reports,2015,42(7):1187-1195.

[26] Johnson A P,Mikac K M,Wallman J F.Thermogenesis in decomposing carcasses[J].Forensic Science International,2013,231(1-3):271-277.

[27] Suarez-Zamorano N,Fabbiano S,Chevalier C,et al.Microbiota depletion promotes browning of white adipose tissue and reduces obesity[J].Nature Medicine,2015,21(12):1497-1501.

[28] Pollet R M,D＇agostino E H,Walton W G,et al.An atlas of beta-glucuronidases in the human intestinal microbiome[J].Structure,2017,25(7):967-977.

[29] Roberts A B,Wallace B D,Venkatesh M K,et al.Molecular insights into microbial beta-glucuronidase inhibition to abrogate CPT-11 toxicity[J].Molecular Pharmacology,2013,84(2):208-217.

[30] Piwowarski J P,Stanislawska I,Granica S,et al.Phase‖conjugates of urolithins isolated from human urine and potential role of beta-glucuronidases in their disposition[J].Drug Metabolism and Disposition:The Biological Fate of Chemicals,2017,45(6):657-665.

[31] G.Jezequel S.Microbial models of mammalian metabolism:uses and misuses(clarification of some misconceptions)[J].Journal of Molecular Catalysis B:Enzymatic,1998,5(1-4):371-377.

[32] Koppel N,Maini Rekdal V,Balskus E P.Chemical transformation of xenobiotics by the human gut microbiota[J].Science,2017,356(6344):eaag2770.

[33] Harmsen H J,De Goffau M C.The human gut microbiota[J].Advances in Experimental Medicine and Biology,2016,902:95-108.

[34] Macfarlane S,Macfarlane G T.Regulation of short-chain fatty acid production[J].Proceedings of the Nutrition Society,2003,62(1):67-72.

[35] Bourriaud C,Robins R J,Martin L,et al.Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident[J].Journal of Applied Microbiology,2005,99(1):201-212.

[36] Cantarel B L,Lombard V,Henrissat B.Complex carbohydrate utilization by the healthy human microbiome[J].PloS One,2012,7(6):e28742.

[37] Sidhu H,Hoppe B,Hesse A,et al.Absence of Oxalobacter formigenes in cystic fibrosis patients:a risk factor for hyperoxaluria[J].Lancet,1998,352(9133):1026-1029.

[38] Magwira C A,Kullin B,Lewandowski S,et al.Diversity of faecal oxalate-degrading bacteria in black and white South African study groups:insights into understanding the rarity of urolithiasis in the black group[J].Journal of Applied Microbiology,2012,113(2):418-428.

[39] Hooper L V,Wong M H,Thelin A,et al.Molecular analysis of commensal host-microbial relationships in the intestine[J].Science,2001,291(5505):881-884.

[40] Devillard E,Mcintosh F M,Paillard D,et al.Differences between human subjects in the composition of the faecal bacterial community and faecal metabolism of linoleic acid[J].Microbiology,2009,155(Pt 2):513-520.

[41] Fukiya S,Arata M,Kawashima H,et al.Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces[J].FEMS Microbiology Letters,2009,293(2):263-270.

[42] Thomas C M,Hong T,Van Pijkeren J P,et al.Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling[J].PloS One,2012,7(2):e31951.

[43] De Biase D,Pennacchietti E.Glutamate decarboxylase-dependent acid resistance in orally acquired bacteria:function,distribution and biomedical implications of the gadBC operon[J].Molecular Microbiology,2012,86(4):770-786.

[44] Marin L,Miguelez E M,Villar C J,et al.Bioavailability of dietary polyphenols and gut microbiota metabolism:antimicrobial properties[J].Biomed Res Int,2015,2015:905215.

[45] Lopez-Boado Y S,Wilson C L,Hooper L V,et al.Bacterial exposure induces and activates matrilysin in mucosal epithelial cells[J].Journal of Cell Biology,2000,148(6):1305-1315.

[46] Alakomi H L,Skytta E,Saarela M,et al.Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane[J].Applied and Environmental Microbiology,2000,66(5):2001-2005.

[47] Kida Y,Shimizu T,Kuwano K.Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line,EBC-1[J].Molecular Immunology,2006,43(12):1972-1981.

[48] Verdu E F,Galipeau H J,Jabri B.Novel players in coeliac disease pathogenesis:role of the gut microbiota[J].Nature Reviews:Gastroenterology&Hepatology,2015,12(9):497-506.

[49] Belkaid Y,Hand T W.Role of the microbiota in immunity and inflammation[J].Cell,2014,157(1):121-141.

[50] Moro K,Koyasu S.Innate lymphoid cells,possible interaction with microbiota[J].Seminars in Immunopathology,2015,37(1):27-37.

[51] Kinnebrew M A,Buffie C G,Diehl G E,et al.Interleukin 23 production by intestinal CD103(+)CD11b(+)dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense[J].Immunity,2012,36(2):276-287.

[52] Duan Q,Zhou M,Zhu L,et al.Flagella and bacterial pathogenicity[J].Journal of Basic Microbiology,2013,53(1):1-8.

[53] Wang Y,Yin Y,Chen X,et al.Induction of intestinal Th17 cells by flagellins from segmented filamentous bacteria[J].Frontiers in Immunology,2019,10:2750.

[54] Geuking M B,Cahenzli J,Lawson M A,et al.Intestinal bacterial colonization induces mutualistic regulatory T cell responses[J].Immunity,2011,34(5):794-806.

[55] Smith P M,Howitt M R,Panikov N,et al.The microbial metabolites,short-chain fatty acids,regulate colonic Treg cell homeostasis[J].Science,2013,341(6145):569-573.

[56] Singh N,Gurav A,Sivaprakasam S,et al.Activation of Gpr109a,receptor for niacin and the commensal metabolite butyrate,suppresses colonic inflammation and carcinogenesis[J].Immunity,2014,40(1):128-139.

[57] Lutgendorff F,Akkermans L M,Soderholm J D.The role of microbiota and probiotics in stress-induced gastro-intestinal damage[J].Current Molecular Medicine,2008,8(4):282-298.

[58] Yan F,Cao H,Cover T L,et al.Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism[J].Journal of Clinical Investigation,2011,121(6):2242-2253.

[59] Cani P D,Possemiers S,Van De Wiele T,et al.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability[J].Gut,2009,58(8):1091-1103.

[60] Stappenbeck T S,Hooper L V,Gordon J I.Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(24):15451-15455.

[61] Banasaz M,Norin E,Holma R,et al.Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG[J].Applied and Environmental Microbiology,2002,68(6):3031-3034.

[62] Hooper L V,Gordon J I.Commensal host-bacterial relationships in the gut[J].Science,2001,292(5519):1115-1118.

[63] Modi S R,Collins J J,Relman D A.Antibiotics and the gut microbiota[J].Journal of Clinical Investigation,2014,124(10):4212-4218.

[64] Baumler A J,Sperandio V.Interactions between the microbiota and pathogenic bacteria in the gut[J].Nature,2016,535(7610):85-93.

[65] Hasegawa M,Kamada N,Jiao Y,et al.Protective role of commensals against Clostridium difficile infection via an IL-1beta-mediated positive-feedback loop[J].Journal of Immunology,2012,189(6):3085-3091.

[66] Song J H,Kim Y S.Recurrent clostridium difficile infection:risk factors,treatment,and prevention[J].Gut Liver,2019,13(1):16-24.

[67] Lozupone C A,Stombaugh J I,Gordon J I,et al.Diversity,stability and resilience of the human gut microbiota[J].Nature,2012,489(7415):220-230.

[68] Schamberger G P,Diez-Gonzalez F.Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7[J].Journal of Food Protection,2002,65(9):1381-1387.

[69] Shin R,Suzuki M,Morishita Y.Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7[J].Journal of Medical Microbiology,2002,51(3):201-206.

[70] Fukuda S,Toh H,Hase K,et al.Bifidobacteria can protect from enteropathogenic infection through production of acetate[J].Nature,2011,469(7331):543-547.

[71] Kiss E A,Vonarbourg C,Kopfmann S,et al.Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles[J].Science,2011,334(6062):1561-1565.

[72] Fabich A J,Jones S A,Chowdhury F Z,et al.Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine[J].Infection and Immunity,2008,76(3):1143-1152.

[73] Le Bouguenec C,Schouler C.Sugar metabolism,an additional virulence factor in enterobacteria[J].International Journal of Medical Microbiology,2011,301(1):1-6.

[74] Bertin Y,Girardeau J P,Chaucheyras-Durand F,et al.Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content[J].Environmental Microbiology,2011,13(2):365-377.

[75] Kamada N,Kim Y G,Sham H P,et al.Regulated virulence controls the ability of a pathogen to compete with the gut microbiota[J].Science,2012,336(6086):1325-1329.

[76] Fischbach M A,Lin H,Liu D R,et al.How pathogenic bacteria evade mammalian sabotage in the battle for iron[J].Nature Chemical Biology,2006,2(3):132-138.

[77] Furne J,Springfield J,Koenig T,et al.Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues:a specialized function of the colonic mucosa[J].Biochemical Pharmacology,2001,62(2):255-259.

[78] Winter S E,Thiennimitr P,Winter M G,et al.Gut inflammation provides a respiratory electron acceptor for Salmonella[J].Nature,2010,467(7314):426-429.

[79] Winter S E,Winter M G,Xavier M N,et al.Host-derived nitrate boosts growth of E.coli in the inflamed gut[J].Science,2013,339(6120):708-711.

[80] Wu L,Estrada O,Zaborina O,et al.Recognition of host immune activation by Pseudomonas aeruginosa[J].Science,2005,309(5735):774-777.

[81] Kamada N,Chen G Y,Inohara N,et al.Control of pathogens and pathobionts by the gut microbiota[J].Nature Immunology,2013,14(7):685-690.

[82] Mead P S,Slutsker L,Dietz V,et al.Food-related illness and death in the United States[J].Emerging Infectious Diseases,1999,5(5):607-625.

[83] Bintsis T.Foodborne pathogens[J].AIMS Microbiol,2017,3(3):529-563.

[84] Zhang M,Sun K,Wu Y,et al.Interactions between intestinal microbiota and host immune response in inflammatory bowel disease[J].Frontiers in Immunology,2017,8:942.

[85] Rashid M U,Zaura E,Buijs M J,et al.Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods[J].Clinical Infectious Diseases,2015,60 Suppl 2:S77-84.

[86] Jernberg C,Lofmark S,Edlund C,et al.Long-term ecological impacts of antibiotic administration on the human intestinal microbiota[J].ISME J,2007,1(1):56-66.

[87] Galdston I.Eubiotic medicine[J].Science,1944,100(2587):76.

[88] Vervoort J,Xavier B B,Stewardson A,et al.Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota[J].Journal of Antimicrobial Chemotherapy,2015,70(7):1989-1992.

[89] Stewardson A J,Gaia N,Francois P,et al.Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections:a culture-free analysis of gut microbiota[J].Clinical Microbiology and Infection,2015,21(4):344 e1-11.

[90] Hansen C H,Krych L,Nielsen D S,et al.Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse[J].Diabetologia,2012,55(8):2285-2294.

[91] Shin N R,Lee J C,Lee H Y,et al.An increase in the Akkermansia spp.population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice[J].Gut,2014,63(5):727-735.

[92] Gu Y,Wang X,Li J,et al.Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment[J].Nat Commun,2017,8(1):1785.

[93] Zheng J,Zhu L,Hu B,et al.1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis[J].The Journal of Nutritional Biochemistry,2019,71:16-26.

[94] Khan N,Mukhtar H.Tea polyphenols in promotion of human health[J].Nutrients,2018,11(1):39.

[95] Ozdal T,Sela D A,Xiao J,et al.The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility[J].Nutrients,2016,8(2):78.

[96] Kim D H.Gut microbiota-mediated drug-antibiotic interactions[J].Drug Metabolism and Disposition:The Biological Fate of Chemicals,2015,43(10):1581-1589.

[97] Feng W,Ao H,Peng C,et al.Gut microbiota,a new frontier to understand traditional Chinese medicines[J].Pharmacological Research,2019,142:176-191.

[98] Hasegawa H,Sung J H,Benno Y.Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins[J].Planta Medica,1997,63(5):436-440.

[99] Feng R,Shou J W,Zhao Z X,et al.Transforming berberine into its intestine-absorbable form by the gut microbiota[J].Scientific Reports,2015,5:12155.

[100] Ochiai R,Sugiura Y,Shioya Y,et al.Coffee polyphenols improve peripheral endothelial function after glucose loading in healthy male adults[J].Nutrition Research,2014,34(2):155-159.

[101] Choi E J,Kim G H.The antioxidant activity of daidzein metabolites,Odesmethylangolensin and equol,in HepG2 cells[J].Mol Med Rep,2014,9(1):328-332.

[102] Woo T W,Chang M S,Chung Y K,et al.Inhibitory action of YJA20379,a new proton pump inhibitor on Helicobacter pylori growth and urease[J].Archives of Pharmacal Research,1998,21(1):6-11.

[103] Kim D H,Jung E A,Sohng I S,et al.Intestinal bacterial metabolism of flavonoids and its relation to some biological activities[J].Archives of Pharmacal Research,1998,21(1):17-23.

[104] Akao T,Kawabata K,Yanagisawa E,et al.Baicalin,the predominant flavone glucuronide of scutellariae radix,is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form[J].Journal of Pharmacy and Pharmacology,2000,52(12):1563-1568.

[105] Carter J H,Mclafferty M A,Goldman P.Role of the gastrointestinal microflora in amygdalin(laetrile)-induced cyanide toxicity[J].Biochemical Pharmacology,1980,29(3):301-304.

[106] Xu J,Chen H B,Li S L.Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota[J].Medicinal Research Reviews,2017,37(5):1140-1185.